DIMENSIONAL FUND ADVISORS LP - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$271,000
+45.7%
132,385
+104.9%
0.00%
Q4 2021$186,000
-32.1%
64,6230.0%0.00%
Q3 2021$274,000
-2.8%
64,623
+21.2%
0.00%
Q2 2021$282,000
+10.6%
53,312
-2.8%
0.00%
Q1 2021$255,000
+40.9%
54,8660.0%0.00%
Q4 2020$181,000
-0.5%
54,8660.0%0.00%
Q3 2020$182,000
-1.6%
54,8660.0%0.00%
Q2 2020$185,000
-23.9%
54,866
-13.4%
0.00%
Q1 2020$243,000
-26.6%
63,328
+15.4%
0.00%
Q4 2019$331,000
-21.7%
54,866
-1.9%
0.00%
Q3 2019$423,000
-44.2%
55,9430.0%0.00%
Q2 2019$758,000
+150.2%
55,9430.0%0.00%
Q1 2019$303,000
+82.5%
55,9430.0%0.00%
Q4 2018$166,000
-67.5%
55,943
-10.7%
0.00%
Q3 2018$511,000
-16.2%
62,6700.0%0.00%
Q2 2018$610,000
+24.2%
62,670
+11.0%
0.00%
Q1 2018$491,000
-30.6%
56,4750.0%0.00%
Q4 2017$707,00056,4750.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders